Yukiko Tanaka

Dr. Yukiko Tanaka

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2021 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
TSTakuya Sugahara
Takuya Sugahara
YTYukiko Tanaka
Yukiko Tanaka
Masahide HamaguchiMasahide Hamaguchi
Masahide Hamaguchi
MFMaya Fujii
Maya Fujii
KSKoki Shimura
Koki Shimura
JKJo Kitawaki
Jo Kitawaki

1 June 2016 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
FIFumitake Ito
Fumitake Ito
TMTaisuke Mori
Taisuke Mori
OTOsamu Takaoka
Osamu Takaoka
YTYukiko Tanaka
Yukiko Tanaka
AKAkemi Koshiba
Akemi Koshiba
JKJo Kitawaki
Jo Kitawaki

1 February 2023 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
MFMaya Fujii
Maya Fujii
YTYukiko Tanaka
Yukiko Tanaka
HOHiroyuki Okimura
Hiroyuki Okimura
EMEiko Maeda
Eiko Maeda
MHMasahide Hamaguchi
Masahide Hamaguchi
TMTaisuke Mori
Taisuke Mori

28 March 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
KLKEIBUN LIU
KEIBUN LIU
Toru KotaniToru Kotani
Toru Kotani
KNKensuke Nakamura
Kensuke Nakamura
TCTakai Chihiro
Takai Chihiro
YMYasunari Morita
Yasunari Morita
TOTakayuki Ogura
Takayuki Ogura
Introduction Sepsis is not only the leading cause of death in the intensive care unit (ICU) but also a major risk factor for physical and cognitive impairment and mental disorders, known as postintensive care syndrome (PICS), reduced health-related quality of life (HRQoL) and even mental health disorders in patient families (PICS-family; PICS-F). The ABCDEF bundle is strongly recommended to overcome them, while the association between implementing the bundle and the long-term outcomes is also unknown. Methods and analysis This is a multicentre prospective observational study at 26 ICUs. All consecutive patients between 1 November 2020 and 30 April 2022, who are 18 years old or older and expected to stay in an ICU for more than 48 hours due to sepsis or septic shock, are enrolled. Follow-up to evaluate survival and PICS/ PICS-F will be performed at 3, 6 and 12 months and additionally every 6 months up to 5 years after hospital discharge. Primary outcomes include survival at 12 months, which is the primary outcome, and the incidence of PICS defined as the presence of any physical impairment, cognitive impairment or mental disorders. PICS assessment scores, HRQoL and employment status are evaluated. The association between the implementation rate for the ABCDEF bundle and for each of the individual elements and long-term outcomes will be evaluated. The PICS-F, defined as the presence of mental disorders, and HRQoL of the family is also assessed. Additional analyses with data up to 5 years follow-up are planned. Ethics and dissemination This study received ethics approvals from Saiseikai Utsunomiya Hospital (2020-42) and all other participating institutions and was registered in the University Hospital Medical Information Network Clinical Trials Registry. Informed consent will be obtained from all patients. The findings will be published in peer-reviewed journals and presented at scientific conferences. Trial registration number UMIN000041433.


1 January 1992 in Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Verified
Journal Article
Open access
PDF file
YTYukiko Tanaka
Yukiko Tanaka